BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23829359)

  • 21. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
    Dalterio S; Steger R; Mayfield D; Bartke A
    Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.
    Lutge EE; Gray A; Siegfried N
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005175. PubMed ID: 23633327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study.
    van Hell HH; Bossong MG; Jager G; Kristo G; van Osch MJ; Zelaya F; Kahn RS; Ramsey NF
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1377-88. PubMed ID: 21489346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cannabis use on salience attribution: a systematic review.
    Wijayendran SB; O'Neill A; Bhattacharyya S
    Acta Neuropsychiatr; 2018 Feb; 30(1):43-57. PubMed ID: 27866486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of THC and CBD in Schizophrenia: A Systematic Review.
    Ahmed S; Roth RM; Stanciu CN; Brunette MF
    Front Psychiatry; 2021; 12():694394. PubMed ID: 34366924
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perinatal exposure to cannabinoids alters neurochemical development in rat brain.
    Walters DE; Carr LA
    Pharmacol Biochem Behav; 1988 Jan; 29(1):213-6. PubMed ID: 2895481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date.
    Sami MB; Rabiner EA; Bhattacharyya S
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1201-24. PubMed ID: 26068702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids in Pain Management and Palliative Medicine.
    Häuser W; Fitzcharles MA; Radbruch L; Petzke F
    Dtsch Arztebl Int; 2017 Sep; 114(38):627-634. PubMed ID: 29017688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cannabis on the adolescent brain.
    Jacobus J; Tapert SF
    Curr Pharm Des; 2014; 20(13):2186-93. PubMed ID: 23829363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids for the treatment of dementia.
    Krishnan S; Cairns R; Howard R
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD007204. PubMed ID: 19370677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THC and CBD effects on alcohol use among alcohol and cannabis co-users.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Psychol Addict Behav; 2021 Sep; 35(6):749-759. PubMed ID: 33764086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychoactive constituents of cannabis and their clinical implications: a systematic review.
    Casajuana Köguel C; López-Pelayo H; Balcells-Olivero MM; Colom J; Gual A
    Adicciones; 2018 Apr; 30(2):140-151. PubMed ID: 28492950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
    Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
    J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature.
    Lorenzetti V; Solowij N; Fornito A; Lubman DI; Yucel M
    Curr Pharm Des; 2014; 20(13):2138-67. PubMed ID: 23829361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis: toxicological properties and epidemiological aspects.
    Nahas GG
    Med J Aust; 1986 Jul; 145(2):82-7. PubMed ID: 3016488
    [No Abstract]   [Full Text] [Related]  

  • 39. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
    McFadden BR; Malone T
    Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and chronic effects of Δ
    Ogunbiyi MO; Hindocha C; Freeman TP; Bloomfield MAP
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109900. PubMed ID: 32109508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.